Gregory T. Lucier is CEO at INVITROGEN CORP (IVGN). They have made 52 open-market trades across 9 companies since 2006, most recently 2026-06-09.
CIK 0001251299
35 open-market purchases totalling $15.4M since 2006, against 17 sales. Across 32 scored buys the stock is up 9.4% at ninety days, and 6.1 points ahead of the S&P over the same stretch.
32 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 44% | 50% | 50% |
| Avg Move | -0.3% | +2.5% | +9.4% |
| Alpha | +0.3% | +2.9% | +6.1% |
| Scored | 32 | 32 | 32 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVTR | BUY | 2026-05-08 | 2026-05-11 | $8.32 | $83K | -2.5% | +19.7% | +70.5% |
| XRAY | BUY | 2026-03-09 | 2026-03-09 | $12.45 | $187K | -13.1% | -7.4% | -20.8% |
| XRAY | BUY | 2026-03-02 | 2026-03-03 | $14.15 | $708K | -16.4% | -15.7% | -27.4% |
| AVTR | BUY | 2026-02-19 | 2026-02-23 | $9.16 | $458K | -4.4% | -13.7% | -8.6% |
| XRAY | SELL | 2025-12-08 | 2025-12-10 | $11.14 | $916K | -3.6% | +9.4% | +8.6% |
| MRVI | BUY | 2025-12-05 | 2025-12-09 | $3.69 | $737K | -12.3% | -1.5% | -7.2% |
| XRAY | BUY | 2025-03-03 | 2025-03-03 | $16.51 | $500K | -6.6% | -7.4% | -2.7% |
| XRAY | BUY | 2024-11-15 | 2024-11-18 | $18.36 | $110K | +7.1% | +1.9% | +2.7% |
| XRAY | BUY | 2024-08-08 | 2024-08-09 | $24.35 | $400K | +0.9% | +4.0% | -29.2% |
| XRAY | BUY | 2024-05-31 | 2024-06-03 | $27.95 | $200K | -4.9% | -11.8% | -10.9% |
| XRAY | BUY | 2023-11-22 | 2023-11-27 | $31.44 | $314K | +2.6% | +12.6% | +6.4% |
| XRAY | BUY | 2022-11-15 | 2022-11-15 | $31.45 | $189K | -2.8% | -0.3% | +17.7% |
| BLI | BUY | 2022-03-11 | 2022-03-15 | $5.24 | $262K | +17.5% | +3.1% | -27.6% |
| CTLT | SELL | 2021-11-23 | 2021-11-24 | $127.22 | $984K | -5.1% | -2.9% | -24.8% |
| BLI | BUY | 2021-11-05 | 2021-11-09 | $24.15 | $1.0M | -5.6% | -26.3% | -67.3% |
| BLI | BUY | 2021-06-03 | 2021-06-07 | $41.12 | $206K | +11.1% | +5.8% | -16.0% |
| XRAY | BUY | 2021-03-04 | 2021-03-05 | $58.75 | $529K | +5.9% | +7.3% | +11.0% |
| MRVI | BUY | 2020-11-24 | 2020-11-25 | $27.00 | $405K | -6.6% | +5.1% | +19.7% |
| CTLT | SELL | 2020-07-30 | 2020-08-03 | $90.09 | $2.2M | -1.4% | -0.2% | -1.2% |
| BLI | BUY | 2020-07-16 | 2020-07-20 | $22.00 | $500K | -10.1% | -11.5% | +15.0% |
| CTLT | BUY | 2020-02-13 | 2020-02-14 | $59.71 | $119K | -13.2% | -35.6% | +16.2% |
| NUVA | SELL | 2019-11-18 | 2019-11-20 | $72.99 | $4.3M | +1.5% | +7.7% | +9.7% |
| CTLT | BUY | 2019-09-09 | 2019-09-11 | $51.64 | $103K | -0.3% | -6.0% | +2.6% |
| XRAY | BUY | 2019-05-23 | 2019-05-23 | $53.60 | $536K | +2.2% | +6.4% | -1.5% |
| CTLT | BUY | 2019-05-09 | 2019-05-13 | $45.08 | $90K | +6.2% | +13.8% | +27.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| BLI |
| 136,062 |
| $163K |
| IVGN | 197,400 | — |
| CFN | 34,103 | — |
| CELL | 206,062 | — |
| Total | $18.9M |
Shares reported on the most recent Form 4, priced at the 2026-06-10 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.